Evidence map›Paper›PMID 11819767›Full record

ArticleWorld journal of gastroenterology2001

Immunohistochemical study of hepatic oval cells in human chronic viral hepatitis.

X Ma, D K Qiu, Y S Peng

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. gC1qR expression in normal and pathologic human tissues: differential expression in tissues of epithelial and mesenchymal origin.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2012
    Article
  5. Article
  6. Possible stem cell origin of human cholangiocarcinoma.World journal of gastroenterology · 2004
    Article
  7. Article
  8. Article
  9. Article
  10. A selective tropism of transfused oval cells for liver.World journal of gastroenterology · 2003
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

X MaShanghai Institute of Digestive Diseases, Renji Hospital, 145 Shandong Zhong Road, Shanghai 200001, China. xiongma@netease.com
D K Qiu
Y S Peng
Renji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo detect immunohistochemically the presence of oval cells in chronic viral hepatitis with antibody against c-kit.

methodsWe detected oval cells in paraffin embedded liver sections of 3 normal controls and 26 liver samples from patients with chronic viral hepatitis, using immunohistochemistry with antibodies against c-kit, piclass glutathione S-transferase (pi-GST) and cytokeratins 19 (CK19).

resultsOval cells were not observed in normal livers. In chronic viral hepatitis, hepatic oval cells were located predominantly in the periportal region and fibrosis septa,characterized by an ovoid nucleus, small size,and scant cytoplasm. Antibody against stem cell factor receptor, c-kit, had higher sensitivity and specificity than pi-GST and CK19. About 50%-70% of c-kit positive oval cells were stained positively for either pi-GST or CK19.

conclusionOval cells are frequently detected in human livers with chronic viral hepatitis, suggesting that oval cell proliferation is associated with the liver regeneration in this condition.

Indexed as

AdultAgedHepatitis, ChronicHepatitis, Viral, HumanHumansImmunoenzyme TechniquesLiver RegenerationMiddle AgedProto-Oncogene Proteins c-kitProto-Oncogene Proteins c-kit

Identifiers

PMID11819767
PMCPMC4723529
OpenAlexW1517581723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.